We are live on ! Find out more
MC

Martin Currie Portfolio holdings

AUM $2.61B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+0.16%
1 Year Est. Return
+29.41%
3 Year Est. Return
+113.59%
5 Year Est. Return
+146.61%
10 Year Est. Return
+447.23%
AUM
$1.16B
AUM Growth
+$8.31M
Cap. Flow
+$14M
Cap. Flow %
1.21%
Top 10 Hldgs %
36.53%
Holding
86
New
3
Increased
29
Reduced
36
Closed
4

Top Buys

Rank Stock Value
1
EWT icon
iShares MSCI Taiwan ETF
EWT
+$8.01M
2
CYT
CYTEC INDS INC
CYT
+$5.97M
3
TJX icon
TJX Companies
TJX
+$5.47M
4
VZ icon
Verizon
VZ
+$4.07M
5
KMI icon
Kinder Morgan
KMI
+$3.69M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.67M
2
NOV icon
NOV
NOV
+$3.67M
3
JPM icon
JPMorgan Chase
JPM
+$3.45M
4
ABBV icon
AbbVie
ABBV
+$3.42M
5
MO icon
Altria Group
MO
+$3.35M

Sector Composition

Rank Sector Weight
1 Technology 22.38%
2 Healthcare 13.27%
3 Financials 12.02%
4 Energy 10.14%
5 Communication Services 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFY icon
1
Infosys
INFY
$48.4B
$72.2M 6.2%
9,544,000
-191,200
-2% -$1.38M
CTSH icon
2
Cognizant
CTSH
$24.3B
$49.7M 4.27%
1,110,494
+50,800
+5% +$2.39M
CVX icon
3
Chevron
CVX
$383B
$44.5M 3.83%
373,350
-2,900
-0.8% -$370K
VZ icon
4
Verizon
VZ
$193B
$42.4M 3.64%
847,500
+81,900
+11% +$4.07M
TSM icon
5
TSMC
TSM
$2.09T
$40.3M 3.47%
1,997,475
+163,000
+9% +$3.4M
ABBV icon
6
AbbVie
ABBV
$455B
$40.2M 3.45%
695,300
-61,600
-8% -$3.42M
BAP icon
7
Credicorp
BAP
$32B
$38.9M 3.34%
253,496
+16,694
+7% +$2.56M
PM icon
8
Philip Morris
PM
$299B
$34.8M 2.99%
416,770
-19,000
-4% -$1.61M
PFE icon
9
Pfizer
PFE
$142B
$31.1M 2.67%
1,107,767
-166,532
-13% -$4.67M
EWT icon
10
iShares MSCI Taiwan ETF
EWT
$9.6B
$30.9M 2.66%
1,011,650
+249,200
+33% +$8.01M
AAPL icon
11
Apple
AAPL
$4.9T
$29.9M 2.57%
1,187,804
-77,600
-6% -$1.9M
PG icon
12
Procter & Gamble
PG
$335B
$28.9M 2.48%
344,700
+4,100
+1% +$336K
SRE icon
13
Sempra
SRE
$58.6B
$27M 2.32%
511,824
+5,600
+1% +$289K
KMI icon
14
Kinder Morgan
KMI
$70.5B
$25.6M 2.2%
668,791
+97,000
+17% +$3.69M
CVS icon
15
CVS Health
CVS
$134B
$25.1M 2.15%
314,796
+9,400
+3% +$741K
JPM icon
16
JPMorgan Chase
JPM
$933B
$24.1M 2.07%
400,288
-59,018
-13% -$3.45M
INDA icon
17
iShares MSCI India ETF
INDA
$6.88B
$23.6M 2.03%
778,700
LYB icon
18
LyondellBasell Industries
LYB
$19.5B
$22.3M 1.91%
204,873
-13,100
-6% -$1.42M
CHKP icon
19
Check Point Software Technologies
CHKP
$13.1B
$21M 1.81%
303,800
+14,800
+5% +$1.01M
EBAY icon
20
eBay
EBAY
$50.4B
$19.6M 1.69%
823,046
-1,188
-0.1% -$26.4K
AIG icon
21
American International
AIG
$41.8B
$19.4M 1.67%
359,800
-30,900
-8% -$1.69M
BSAC icon
22
Banco Santander Chile
BSAC
$16.5B
$19.3M 1.66%
875,073
+56,300
+7% +$1.39M
RTX icon
23
RTX Corp
RTX
$289B
$18.9M 1.62%
284,015
-635
-0.2% -$43.5K
MCD icon
24
McDonald's
MCD
$191B
$18M 1.55%
189,925
-17,300
-8% -$1.65M
PNC icon
25
PNC Financial Services
PNC
$99.2B
$17.8M 1.53%
208,295
-600
-0.3% -$51K

Similar funds

Martin Currie's Q3 2014 Portfolio in Review

As of Q3 2014, Martin Currie held 86 positions worth $1.16B, up 0.72% from $1.15B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Martin Currie's Q3 2014 filing shows 3 new, 29 increased, 36 reduced and 4 closed positions. Its largest new stake was TJX Companies: 193,966 shares worth $5.74M. The largest sale was Pfizer, an estimated $4.67M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Martin Currie's largest Q3 2014 buy was TJX Companies: 193,966 shares worth $5.74M.
  • Martin Currie added most to iShares MSCI Taiwan ETF in Q3 2014, an estimated $8.01M increase.
  • Martin Currie's biggest Q3 2014 reduction was Pfizer, cutting an estimated $4.67M.
  • Martin Currie fully exited NOV in Q3 2014, selling an estimated $3.67M.
  • Martin Currie's ten largest holdings make up 37% of its $1.16B portfolio in Q3 2014.
  • Martin Currie opened 3 new positions and closed 4 in Q3 2014.
  • Martin Currie's portfolio value rose 0.72% quarter-over-quarter to $1.16B.

Based on Martin Currie's 13F filing for Q3 2014, filed 28 Oct 2014.